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Dpl (doppel) is a paralogue of the PrP
C (cellular prion protein),
whose misfolded conformer (the scrapie prion protein, PrP
Sc)
is responsible for the onset of TSEs (transmissible spongiform
encephalopathies) or prion diseases. It has been shown that the
ectopic expression of Dpl in the brains of some lines of PrP-
knockout mice provokes cerebellar ataxia, which can be rescued
by the reintroduction of the PrP gene, suggesting a functional
interaction between the two proteins. It is, however, still unclear
where, and under which conditions, this event may occur. In
the present study we addressed this issue by analysing the
intracellular localization and the interaction between Dpl and
PrP
C in FRT (Fischer rat thyroid) cells stably expressing the
two proteins separately or together. We show that both proteins
localize prevalently on the basolateral surface of FRT cells, in
both singly and doubly transfected clones. Interestingly we found
that they associate with DRMs (detergent-resistant membranes)
or lipid rafts, from where they can be co-immunoprecipitated in a
cholesterol-dependent fashion. Although the interaction between
Dpl and PrP
C has been suggested before, our results provide the
ﬁrst clear evidence that this interaction occurs in rafts and is
dependent on the integrity of these membrane microdomains.
Furthermore, both Dpl and PrP
C could be immunoprecipitated
with ﬂotillin-2, a raft protein involved in endocytosis and cell
signalling events, suggesting that they share the same lipid
environment.
Key words: doppel (Dpl), epithelial cell, lipid raft, prion protein
(PrP), protein trafﬁcking.
INTRODUCTION
The PrP
C (cellular prion protein) is a cell-surface glycoprotein of
unknown function expressed in mammalian tissues, particularly
in the CNS (central nervous system) [1]. PrP
C can be misfolded
into the PrP
Sc (scrapie prion protein) isoform, which is the
essentialcomponentoftheprionagentcausingTSE(transmissible
spongiformencephalopathie)orpriondiseases[2].Whereassome
linesofPrP-knockoutmicedisplayanormalphenotype,theNgsk,
Zurich II and Rcm0 lines of PrP-knockout mice develop a late-
onset ataxia [3–5]. This phenotype was not associated with the
absence of PrP
C, but rather with the ectopic brain expression of
aP r P
C paralogue, named doppel (Dpl) [4,6]. Dpl is present in
the CNS during embryogenesis and in the early post-natal life,
whereas in adults it is expressed at high levels mainly in the
testis, where it plays a key role in spermatogenesis [4,7,8]. Dpl is
composed of 179 amino acids encoded by the Prnd [prion protein
2 (dublet)] gene, located approx. 20 kb downstream of the PrP
gene [4]. It is homologous with the structured C-terminal end of
PrP
C, but lacks both the octa-repeat and the hydrophobic domains
present in the ﬂexible N-terminal tail of PrP
C [4,9]. Examination
of post-translational modiﬁcations of Dpl and PrP
C have shown
that the two proteins share several biochemical features: both
have two N-linked oligosaccharide groups, are anchored to the
external cell surface by a GPI (glycophosphatidylinositol) moiety
and form intramolecular disulﬁde bonds [4,9–11].
Interestingly, the expression of Dpl, or of some PrP-deletion
mutantscloselyresemblingDpl,intransgenicPrP-knockoutmice
causes cerebellar degeneration that is antagonized by wild-type
PrP
C. This has led to the suggestion that the two proteins may
functionally interact [5,12–16]. More speciﬁcally, it has been
proposed that Dpl competes for a putative PrP
C ligand that is
necessary to transduce a cell survival signal [15–17] or that PrP
C
could block a neurotoxic signal induced by Dpl by competing
for its binding to a third molecule, α-2-macroglobulin [8,18].
Contrasting results on the putative interaction of Dpl with PrP
C
have been reported [18–23]. Indeed, whereas in neuronal cells the
resultssupportaninteractionbetweenthetwoproteins[19,21,24],
in testis such an interaction was not found [20]. Interestingly, and
differently from the testis [20], in cells of neuronal origin both
proteins seem to share common membrane microdomains and
internalization pathways [24]. Speciﬁcally in neuroblastoma cells
PrP
C and Dpl were shown to associate, independently from each
other, to membrane microdomains enriched in cholesterol and
sphingolipids, known as DRMs (detergent-resistant membranes)
or lipid rafts. DRMs are thought to modulate several cellular
events, such as polarized sorting of lipids and proteins, signal
transduction and endocytosis [25], and could also be the site of
PrP
C into PrP
Sc conversion [26–28].
Intriguingly, Uelhoff et al. [29] have shown that the co-
expression of Dpl with PrP
C in polarized MDCK (Madin–Darby
canine kidney) cells prevented the basolateral sorting of PrP
C,
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which was sorted to the apical membrane together with Dpl.
Although a direct interaction between the two proteins was not
demonstrated,theauthorshypothesizedthattheapicalmis-sorting
of PrP
C could be caused by the capacity of Dpl to interact with
PrP
C, masking the basolateral sorting signal possibly present on
this protein, but absent in Dpl.
Having characterized previously the intracellular trafﬁcking
and raft association of PrP
C in FRT (Fischer rat thyroid) cells
[30,31], we set out to investigate the behaviour of Dpl either
transfected alone or together with PrP
C in this cell line. We
focussed our attention on their trafﬁcking and possible physical
and/or functional interaction. In the present study we report
that, in contrast with MDCK cells [29], both proteins localize
prevalently on the basolateral domain of the plasma membrane
and in the Golgi complex of FRT cells and associate with DRMs.
Interestingly we demonstrate that, when expressed together, Dpl
and PrP
C co-immunoprecipitate in DRMs and that this interaction
is impaired by cholesterol depletion. In addition we found
that each protein immunoprecipitates with ﬂotillin-2, a scaffold
protein involved in both endocytosis and signalling in rafts [32],
both independently and together.
EXPERIMENTAL
Reagents and antibodies
The following reagents were used: cell culture reagents
from Euroclone; Protein A–Sepharose from GE Healthcare;
LysotrackerRedDND-99fromMolecularProbes;biotinandHRP
(horseradish peroxidase)-conjugated streptavidin from Pierce
Chemicals; FBS (fetal bovine serum) from Hyclone; and MβCD
(methyl-β-cyclodextrin) and MEV (mevinolin), as well as all the
other reagents, from Sigma–Aldrich. For immunocytochemistry
andbiochemicalassays,thefollowingmonoclonalandpolyclonal
antibodies were used: monoclonal antibody SAF-32 against
PrP (Cayman Chemical); monoclonal antibody Dpl 151 against
Dpl (a gift from Dr J. Grassi, Commisariat a l’Energie
Atomique, Saclay, France); anti-Dpl afﬁnity-puriﬁed rabbit
polyclonal antibody Q55 [produced in-house and raised against
recombinant human Dpl (residues 28–152); all experiments using
animals were in accordance with legal requirements] monoclonal
antibody against GFP (green ﬂuorescent protein; Molecular
Probes); polyclonal antibody against GFP (Clontech); polyclonal
antibodies against CNX (calnexin), EEA1 (early endosome
antigen 1) and CLR (calreticulin) (StressGene Biotechnologies);
polyclonal antibody against giantin (a gift from Dr S.
Bonatti, Universit` a degli Studi di Napoli ‘Federico II’, Napoli,
Italy);anti-ﬂotillin-2monoclonalantibody(SignalTransduction);
monoclonal anti-p58K antibody (Sigma–Aldrich); and mono-
clonal anti-antigen 35/40 kDa antibody (a gift from Dr A.
Quaroni, Cornell University, New York, NY, U.S.A.).
Constructs and transfections
To obtain singly PrP
C-expressing clones, FRT and MDCK
cells were stably transfected with a cDNA encoding 3F4-tagged
murine(mo)PrP
C (agiftfromDrS.Lehmann,CentreNationalde
la Recherche Scientiﬁque, France), with the calcium phosphate
procedure as described previously [33]. Stably transfected PrP
C
clones were selected on the basis of resistance to antibiotic
G418. To obtain GFP–Dpl and Dpl clones, the cells were stably
transfected with pEGFP-C1 in which the GFP was cloned in
the human (hu) Dpl gene, or with a pEGFP in which the human
Dpl gene completely substitutes the GFP coding region [24].
To co-express GFP–Dpl, or Dpl, with PrP
C, we transfected FRT
and MDCK clones stably expressing GFP–Dpl, and carrying
the resistance to the antibiotic neomycin, with a plasmid coding
for moPrP
C, carrying the resistance to zeocin. Alternatively, we
transfected FRT clones, stably expressing moPrP
C and carrying
the resistance to zeocin, with a plasmid coding for huDpl, and
carrying neomycin resistance. The two different genes were
under the control of the strong cytomegalovirus promoter. Stably
transfected clones were selected with zeocin or neomycin and
tested for PrP
C and Dpl expression by immunoﬂuorescence
and Western blotting.
Cell culture and drug treatments
FRTcellsweregrowninF12Coon’smodiﬁedmediumcontaining
5% (v/v) FBS, and MDCK cells were grown in DMEM
(Dulbecco’smodiﬁedEagle’smedium)containing5%(v/v)FBS,
Treatments with MEV and MβCD were carried out as described
in [30,31]. Brieﬂy, FRT cells were plated on dishes or ﬁlters in
F12 Coon’s medium supplemented with 5% (v/v) FBS. After
24 h the plated cells were washed and 10 μMo r3 0μMM E V
was added to the cells in fresh F12 Coon’s medium supplemented
with 5% (v/v) de-lipidated FBS and 200 μMm e v a l o n a t e .M βCD
(10 mM)dissolvedinafreshmedium(20 mMHepes,pH 7.5,and
0.2% BSA) was then added to the cells for 1 h at 37◦C.
Cholesterol determination
To determine the cholesterol level before and after treatment
with MEV/mevalonate and MβCD, we used a colorimetric assay.
Brieﬂy, FRT cells grown in the presence, or in the absence,
of MEV/mevalonate and MβCD were washed twice with PBS,
lysed with appropriate lysis buffer 1 [20 mM Tris/HCl, pH 8.0,
containing 1% Triton X-100, 150 mM NaCl, 5 mM EDTA,
0.2% BSA and a protease inhibitor cocktail (leupeptin, antipain,
pepstatin)], and were then mixed for 5 min at 37◦C with the
Inﬁnity Cholesterol Reagent at a 1:10 ratio (according to
the suggested Sigma–Aldrich protocols). Samples were then
analysed spectrophotometrically at 550 nm.
Treatment with PNGase F (peptide N-glycosidase F), endo H
(endoglycosidase H) and sialidase
Digestion with PNGase F, endo H or sialidase (10 milli-
units/sample) was carried out after boiling the immuno-
precipitated proteins for 5 min, with antibodies against GFP–Dpl
or PrP, in 10 mM EDTA, 0.5% Triton X-100, 0.1% SDS and
1% 2-mercaptoethanol when using PNGase F, and with 0.2 M
sodium citrate and 0.5% SDS (pH 5.5) when using the other
two enzymes. Each treatment was carried out for 16 h at 37◦C.
Before adding endo H and sialidase, additional Triton X-100 was
added to give a ﬁnal concentration of 2.5% (v/v). Samples were
then subjected to SDS/PAGE and analysed by Western blotting
after addition of reducing Laemmli sample buffer (containing
2-mercaptoethanol; 1:10 dilution).
Fluorescence microscopy
Cells were grown on transwell permeable ﬁlter supports or
coverslipsandwerewashedwithPBScontaining1 mMCaCl2 and
1m MM g C l 2 beforebeingﬁxedwith2%(w/v)paraformaldehyde
for 20 min. They were then either permeabilized with 0.075%
saponin or were processed directly, and were used for
immunoﬂuorescence analysis. Images were collected using a
Zeiss laser scanning confocal microscope (LSCM 510), equipped
with a planapo ×63 oil-immersion objective lens (numerical
aperture of 1.4).
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Figure 1 GFP–Dpl and PrPC distribute to the cell surface of singly and doubly transfected FRT clones
(A)Aftergrowthontranswellﬁltersfor4days,singly(FRTPrPC;FRTGFP-Dpl),ordoubly(FRTGFP-Dpl+PrPC),transfectedFRTcellswereﬁxedwith2%(w/v)paraformaldehydeandpermeabilized
with 0.075% saponin, prior to a 20min incubation with the monoclonal antibody SAF-32 (against PrPC) followed by a 20min incubation with the secondary TRITC (tetramethylrhodamine
β-isothiocyanate)-conjugated antibody (red). Localization of Dpl was visualized by exploiting the ﬂuorescence emitted by the GFP tag (green). Images were acquired with a Zeiss laser confocal
microscope (LSCM 510). Scale bar, 10μm. (B) After selective biotinylation of apical (Ap) or basolateral (Bl) surface proteins, biotinylated GFP–Dpl and PrPC were recovered from cell lysates by
immunoprecipitation with the speciﬁc antibodies (anti-GFP and SAF-32 antibodies respectively), and were detected by immunoblotting with HRP-conjugated streptavidin. (C) Percentage of apical
(Ap),orbasolateral(Bl),cell-surfacePrPC andGFP–Dplrelativetothetotaltheapicalandbasolateralsignals,whichwasconsideredas100%.Resultswerequantiﬁedfromﬁvedifferentindependent
experiments and represent the means+ −S.D.
Immunoprecipitation assays
To immunoprecipitate GFP–Dpl, native Dpl and PrP
C, cells were
washed three times with PBS containing 1 mM CaCl2 and 1 mM
MgCl2 and lysed for 20 min in lysis buffer 1. Lysates were
pre-cleared with Protein A–Sepharose beads (5 mg/sample) for
30 min and incubated overnight at 4◦C with 2 mg/ml SAF-
32 antibody, to immunoprecipitate PrP
C, or with a monoclonal
antibodyagainstGFP(1 μg/sample),toimmunoprecipitateGFP–
Dpl (both coupled to Protein A–Sepharose) overnight at 4◦C.
Pelletswerewashedthreetimeswithice-coldlysisbuffer1,boiled
in SDS sample buffer, subjected to SDS/PAGE (12% gels) and
immunoblotted on to nitrocellulose membranes. PrP
C, GFP–Dpl
and native Dpl were revealed by immunoblotting the membranes
with the appropriate antibodies.
Biotinylation assay
Cells were grown for 4 days on the transwell ﬁlters and were
selectively biotinylated and processed as described previously
[33]. Cells were directly lysed for 20 min in the transwell
chamber, using 50 mM Tris/HCl, pH 7.5, containing 0.5%
sodium deoxycholate, 0.5% Triton X-100 and 150 mM NaCl.
Biotinylated PrP
C and GFP–Dpl were immunoprecipitated
with the speciﬁc antibodies and were then revealed with HRP-
conjugatedstreptavidinandECL(enhancedchemiluminescence).
Alternatively, biotinylated PrP
C and native Dpl were immuno-
precipitated with streptavidin beads, and were revealed by
Western blotting using speciﬁc antibodies.
Assay for DRM association
Analysis of Triton X-100-insoluble materials in OptiPrep
TM
density gradients was performed using protocols published
previously [34]. Cells were grown in 150-mm-diameter dishes,
washed in PBS containing 1 mM CaCl2 and 1 mM MgCl2
and lysed for 20 min in lysis buffer 1 on ice. Lysates were
scraped from dishes, passed ten times through a 22-gauge needle,
then OptiPrep
TM was added to give a ﬁnal concentration of
40%, and the resulting mixture was placed at the bottom of
a centrifuge tube. An OptiPrep
TM gradient (5–30% OptiPrep
TM
in 200 mM Tris/HCl, pH 7.5, containing 150 mM NaCl and
1 mM EDTA) was layered on top of the lysates, and samples
were ultracentrifuged at 4◦C for 4 h at 20000 rev./min in an
ultracentrifuge(Optima
TM L90KBeckmanCoulterusingaSW41
rotor;Beckman).Fractions(12of1 mleach)wereharvestedfrom
the top of the gradients. GFP–Dpl, native Dpl and PrP
C were
revealedbyimmunoblottingaftertricloroaceticacidprecipitation,
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Figure 2 GFP–Dpl and PrPC localize in the Golgi apparatus
Doubly transfected FRT cells were treated as in Figure 1(A) before being incubated with SAF-32 (against PrPC; blue) and primary polyclonal antibodies against different markers of intracellular
compartments (CNX for the ER, giantin for Golgi and EEA1 for early endosomes; red). Secondary antibodies were Cy5-conjugated anti-(mouse Ig) antibody and TRITC-conjugated anti-(rabbit Ig)
respectively. To label lysosomes, Lysotracker Red DND-99 (Lys, 1:10000 dilution in cell culture medium) was added to live cells 1 h before ﬁxation and confocal imaging. Dpl was also visualized
through the ﬂuorescence of the GFP tag (green). Confocal microscopy was performed as described in Figure 1(A). The localization of GFP–Dpl and PrPC in the Golgi network is clearly evident from
the merging of their respective signals with giantin. Scale bar, 10μm.
or by immunoprecipitation with the speciﬁc antibodies, after
adjusting the DRM fractions to 1% Triton X-100.
RESULTS
Intracellular and surface distribution of PrPC and GFP–Dpl in singly
and doubly transfected FRT clones
FRTclones,constructedtostablyexpressmoPrPandGFP–huDpl
alone, or together, were selected and tested for the expression of
the proteins by immunoﬂuorescence and Western blot analyses
(results not shown). The cellular localization of the two proteins,
in both singly and doubly transfected clones was ﬁrst analysed
by immunoﬂuorescence performed in permeabilized conditions
on cells grown in a polarized monolayer on polycarbonate ﬁlters
(Figure 1) [33]. We found that, in both cases, PrP
C and GFP–
Dpl distribute in a polarized fashion, mainly along the basolateral
surface of the plasma membrane (Figure 1A), independently of
their expression level (results not shown).
In order to quantify this distribution, ﬁlter-grown singly and
doubly transfected clones were selectively biotinylated from the
apical, or basolateral, surface, and then immunoprecipitated with
the anti-GFP or anti-PrP antibodies. As shown in Figures 1(B)
and 1(C), we found that when co-expressed PrP
C and GFP–
Dpl segregated almost completely to the basolateral surface
(95+ −2.5% and 88+ −4.0% of the total of each protein
respectively) which is similar to when they are expressed alone
(96+ −2.5% and 83+ −6.0% respectively).
These results were in contrast with those observed previously
in transfected MDCK cells, in which singly expressed Dpl
and PrP
C reside in opposite membrane domains (i.e. in
the apical and basolateral surface of the plasma membrane
respectively), whereas in co-transfected cells both were
delivered to the apical membrane [29]. Therefore to try and
understand this discrepancy we repeated the same experiments
in MDCK cells (see Supplementary Figure S1 available
at http://www.BiochemJ.org/bj/425/bj4250341add.htm). As we
could reproduce the results from Uelhoff et al. [29] in MDCK
cells (Supplementary Figures S1A and S1B), the discrepancy in
the results could be explained by the fact that the mechanism
of protein sorting in polarized cells is tissue-speciﬁc, as already
demonstrated for other GPI anchored proteins [35,36].
We then proceeded with the characterization of the
intracellular localization of the two proteins in FRT cells by
double immunoﬂuorescence using antibodies against different
intracellular organelle markers. We found that both PrP
C and
GFP–Dpl localized to the Golgi apparatus and were not in the
ER (endoplasmic reticulum) or in early and late endosomal
compartments (Figure 2). As the same distribution was observed
in cells expressing each protein alone (results not shown, and
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Figure 3 Co-transfected GFP–Dpl and PrPC display different glycosylation patterns, indicating retention of GFP–Dpl in the proximal Golgi network
(A) Glycan attachment to GFP–Dpl and PrPC was analysed after immunoprecipitation of the proteins (with anti-GFP and the anti-SAF-32 antibodies) from the lysates of doubly transfected cells
(FRT GFP-Dpl+PrPC), following a 16h incubation at 37◦C in the absence (−), or in the presence (+), of the indicated deglycosylating enzymes. Immunoblotting was performed with antibodies
against GFP-Dpl and PrPC (SAF-32). (B) The doubly transfected clone, after being ﬁxed and permeabilized (as detailed in Figure 1A), was subjected to a double immunoﬂuorescence assay, using
the monoclonal antibody Dpl 151, against Dpl, and a polyclonal antibody against the ER marker CNX, followed by incubation with an anti-mouse TRITC-conjugated secondary antibody and an
anti-rabbitCy5-conjugatedsecondaryantibody[torevealGFP–Dpl(red)andCNX(blue)respectively].Noco-localizationofthetwosignalswasdetected.Scalebar,10μm.(C)GFP–Dpl-transfected
cells grown on coverslips were ﬁxed with paraformaldehyde and incubated under permeabilized conditions with an antibody against the cis-Golgi marker p58K (red). The cells were then treated with
a TRITC-conjugated secondary antibody and examined with a Zeiss laser confocal microscope (LSCM 510). Clearly, the merge signal indicates that GFP–Dpl (green), assessed by monitoring the
GFP ﬂorescence, resides in the cis- to medial-Golgi compartments. Scale bar, 10μm.
[30]), these results support the hypothesis that PrP
C and GFP–
Dpl do not interfere with each other’s intracellular trafﬁcking in
doubly transfected FRT cells.
Glycosylation pattern of PrPC and GFP–Dpl in singly and doubly
transfected clones
It has been reported previously that the glycosylation pattern of
Dpl is tissue-speciﬁc [20,24,37]. As the glycosylation of proteins
has important implications for their trafﬁcking, function and
for their interaction with other partners [38], we characterized
the glycosylation pattern of PrP
C a n dG F P – D p li nF R Tc e l l s .
After immunoprecipitating the proteins (using antibodies against
PrP
C or GFP), cell lysates were digested with three different de-
glycosylating enzymes, namely PNGase F, endo H and sialidase.
We found that, differently from PrP
C, which was digested by
PNGaseFandsialidase,butnotbyendoH,GFP–Dplwaspartially
sensitive to all of the tested enzymes both in doubly (Figure 3A)
and singly (results not shown) transfected cells. The sensitivity of
Dpl to endo H suggests that the protein could be in part retained
in the ER and/or in the cis-medial Golgi, as modiﬁcations of
oligosaccharides that render proteins resistant to the enzyme
take place later in the secretory pathway (i.e. in medial- or
trans-compartments of the Golgi network). Immunoﬂuorescence
experiments using speciﬁc antibodies against ER- or Golgi-
resident proteins (Figure 2) indicated that GFP–Dpl does not
reside in the ER. However, because we followed the ﬂuorescence
ofGFP,itwasnecessarytodiscountthepossibilitythatGFPfailed
to ﬂuoresce properly in the ER [39]. We thus performed double
immunoﬂuorescence experiments, using an antibody against Dpl
together with an antibody against the ER marker CNX or an
antibody against p58K, which labels the cis-Golgi compartment.
As shown in Figures 3(B) and 3(C), the ﬂuorescent signal of Dpl
co-localized with p58K, but not with CNX, thus conﬁrming that
GFP–Dpl resides in the cis- to medial-Golgi and not in the ER.
Association of PrPC and GFP–Dpl to DRMs
Both Dpl and PrP
C have been found to be associated with DRMs
in different cells and tissues [20,24,26]. As this association
could have a role in the trafﬁcking and function of the two
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Figure 4 Association of GFP–Dpl and PrPC to DRMs
(A and B) Singly or doubly transfected clones were grown on 150-mm dishes in the (A) absence (control) or (B) presence (MEV/MβCD) of the cholesterol-depleting agents MEV/mevalonate
and MβCD. After cell lysis in 1% Triton X-100, 2mg of total protein were run through a two-step OptiPrepTM density gradient (5–30%) (see the Experimental section, and [34]). Fractions (12
of 1ml each) were collected from the top of the tube after centrifugation to equilibrium. Each fraction was acid-precipitated and immunoblotted using a polyclonal antibody against GFP and/or
the monoclonal antibody SAF-32 against PrP. As shown in the control samples (A), fractions 4 and 5, which are the richest in DRMs, contained most of GFP–Dpl both in singly and doubly
transfected cells, whereas PrPC migrated to these fractions only to a minor extent in doubly transfected cells. In (B) it is shown that, after cell cholesterol depletion in singly transfected cells
GFP–Dpl and PrPC ﬂoated to heavier density fractions, whereas in doubly transfected cells the distribution of the proteins remained practically unaffected compared with control conditions.
(C) Relative percentage of DRM-associated (DRMs) and DRM-unassociated (NON DRMs) GFP–Dpl and PrPC under the different conditions. The amount of each protein was calculated by setting
the amount of total protein distributed in the 12 fractions of the gradient as 100%, and represents means+ −S.D. (n=4). Distribution of ﬂotillin-2 along the fractions of the gradient (bottom panel)
was used as control for the procedure.
proteins, especially with regards to their interaction, we analysed
the association of PrP
C and GFP–Dpl with these lipid domains
by following their distribution on OptiPrep
TM density gradients
after extraction of the cells in an non-ionic detergent. We
found that, in singly transfected clones, the majority of PrP
C
(60+ −2.1% of the total) and GFP–Dpl (65+ −5.3% of the total)
associatedwiththelow-densityDRM-richfractions4and5ofthe
gradients (Figures 4A and 4C). However, in doubly expressing
clones, only GFP–Dpl maintained this distribution (65+ −5.3
and 62+ −2.4%); PrP
C ﬂoated into DRM fractions in minor
proportions compared with singly transfected clones (36+ −1.8%
compared with 60+ −2.1%; Figures 4A and 4C). These results
suggested that the expression of Dpl affected the distribution of
PrP
C in DRMs. A similar observation was reported previously in
neuronal cells in which co-transfected Dpl and PrP
C partitioned
to a greater extent with high-density fractions [24].
Inordertofurthercharacterizethebehaviourofthetwoproteins
when expressed together we analysed whether cholesterol, a key
structural and functional component of DRMs, was implicated
in the association of PrP
C and GFP–Dpl with DRMs. To this
aim we depleted the cells of approx. 50% of their cholesterol
content, using a combined treatment with MEV/mevalonate and
MβCD [30,31]. As expected, in singly transfected clones this
treatment caused the redistribution of the majority of each protein
to the high-density fractions of the gradient (fraction numbers
8–12). This behaviour was in parallel with that of the DRM
marker ﬂotillin-2 [32] both in singly (results not shown) and
doubly transfected clones (Figure 4). Intriguingly, cholesterol
depletion of doubly transfected clones had no gross effect on
the raft association of GFP–Dpl and PrP
C, in that the proteins
migratedtotheraftfractionsofthegradientstoapproximatelythe
sameextentasthatobservedundercontrolconditions(60+ −1.5%
compared with 62+ −2.4% for GFP–Dpl; 33+ −1.5% compared
with 36+ −1.8% for PrP
C; Figure 4). These results indicated
that when co-expressed the association of both proteins to
membrane microdomains became less sensitive to cholesterol
depletionandsuggeststhattheymightoccupythesamemembrane
microdomains.
Interaction between PrPC and GFP–Dpl
Double immunoﬂuorescence and ﬂotation experiments indicated
that GFP–Dpl and PrP
C co-localize to a good extent and that they
partition in DRMs with similar characteristics. To understand
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Figure 5 GFP–Dpl and PrPC residing in the DRM fractions co-immunoprecipitate
(A) Total protein (2mg) of doubly transfected cells grown in control (control) or cholesterol-depleting (MEV/MβCD), conditions were subjected to OptiPrepTM density gradient puriﬁcation and each
gradient fraction was immunoprecipitated (IP) using a monoclonal antibody against GFP (α-GFP). The immunoprecipitate was then immunolabelled with a monoclonal antibody (SAF-32) against
PrP. (*) indicates immunoglobulins. (B) To conﬁrm the occurrence of the immunoprecipitation, membranes from (A) were stripped and probed with a polyclonal antibody against GFP. (C) The
loading control (L, 60μg of total FRT GFP-Dpl+PrPC lysate), the anti-GFP antibody-immunoprecipitated DRM fraction 4 (IP), 1/10 of the supernatant (SN) and the pre-clearing (PC, precleared of
the immunoprecipitated beads) material were subjected to immunoblotting with the monoclonal antibody SAF-32 against PrP (to indicate co-immunoprecipitation) (top panel). The membrane was
stripped and blotted with a monoclonal antibody against the antigen 35/40kDa (Ag35/40) to conﬁrm the speciﬁcity of the co-immunoprecipitation between GFP–Dpl and PrPC (middle panel). To
conﬁrm the occurrence of the immunoprecipitation, the membrane was stripped and hybridized with a polyclonal antibody against GFP (bottom panel). WB, Western blot.
whether the two proteins entertained physical interactions in
DRMs, we subjected them to co-immunoprecipitation after ﬁrst
being separated by OptiPrep
TM ﬂotation assays. Speciﬁcally, we
ﬁrst immunoprecipitated GFP–Dpl from all OptiPrep
TM fractions
and then immuno-identiﬁed PrP
C in the precipitate by Western
blot analysis. As shown in the upper panels of Figures 5(A) and
5(B), GFP–Dpl and PrP
C could be co-immunoprecipitated only
from DRM fraction 4 of the gradients. Importantly, the same held
true when using an antibody against PrP
C in the precipitation step
and one against GFP to visualize GFP–Dpl in the Western blot of
the immunoprecipitate (see Supplementary Figure S2 available
at http://www.BiochemJ.org/bj/425/bj4250341add.htm). This
interaction appeared to be speciﬁc as we did not observe co-
immunoprecipitation with another basolateral marker, antigen
35/40 kDa [40] (Figure 5C). Furthermore, we observed a
signiﬁcant diminution in the amount of co-immunoprecipitated
PrP
C when performing the experiment in cells depleted of
cholesterol (Figures 5A and 5B, lower panels). Overall, these
results indicate that the two proteins interact within DRMs and
that this interaction requires the integrity of these membrane
microdomains.
Interaction of PrPC and GFP–Dpl with ﬂotillin-2
Although little is known about Dpl interactors it has been shown
that it can interact with ﬂotillin-2 in testis [20]. Interestingly,
PrP
C was also found to interact with ﬂotillin-2 and ﬂotillin-1 in
T-cells[41],butnotintestis[20].Asﬂotillinshavebeenproposed
to have a role both in the endocytosis and function of PrP
C
[42–44], we then analysed whether ﬂotillin-2 interacted with
Dpl and/or PrP
C in singly and/or doubly transfected FRT cells.
To this end, we performed co-immunoprecipitation experiments
using antibodies against GFP–Dpl or PrP
C in the precipitation
step, and used an antibody against ﬂotillin-2 to reveal this protein
in the immunoprecipitate by Western blot analysis. Intriguingly,
we found that both PrP
C and GFP–Dpl co-immunoprecipitated
with ﬂotillin-2 both in singly (Figure 6A) and doubly (Figure 6B)
transfectedclones.Theseﬁndingshighlightthepossibleexistence
of membrane protein complexes in which ﬂotillin-2 associates
with PrP
C and Dpl, either alone or together.
Characterization of clones expressing native Dpl alone or together
with PrPC
In all of the above experiments, we used a construct of Dpl tagged
to GFP. This strategy was chosen for practical reasons, in view
of the possibility to directly follow Dpl through the ﬂuores-
cence of GFP. Although it was previously shown in neuronal cells
that GFP–Dpl behaves like the wild-type protein [24], in order to
discard a possible interference of the tag with the metabolism of
native Dpl in our cell system, we stably transfected FRT clones
with native Dpl alone, or together with PrP
C, and repeated all
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Figure 6 GFP–Dpl and PrPC co-immunoprecipitate with ﬂotillin-2 in both singly and doubly transfected clones
Lysatesfrom(A)singly(FRTGFP-Dpl;FRTPrPC)or(B)doubly(FRTGFP-Dpl+PrPC)transfectedFRTcellswereimmunoprecipitated(IP)withamonoclonalantibodyagainstGFP(left-handpanels)
or the monoclonal antibody SAF-32 against PrP (right-hand panels), and immunolabelled with a monoclonal antibody against ﬂotillin-2 (α-ﬂo-2) to indicate co-immunoprecipitation. Lysate loading
control (L) and 1/10 of the supernatant of the IP (SN) were also analysed. Each membrane was then stripped and further immunolabelled with antibodies against GFP (α- G F P )o rP r P C (α-PrP) to
conﬁrm the occurrence of the immunoprecipitation. WB, Western blot.
the experiments shown for GFP–Dpl in these clones (see the
Experimental section). We found that native Dpl behaved like
GFP–Dpl. In particular we show that in FRT cells native Dpl: (i)
segregated to the basolateral plasma membrane (Figure 7A); (ii)
did not interfere with the basolateral sorting of PrP
C (Figure 7B);
(iii)didnotresideintheER(Figure7C);(iv)wassensitivetoendo
H digestion both when expressed alone (results not shown) and
together with PrP
C (Figure 7D); (v) associated with DRMs both
in singly (results not shown) and doubly (Figure 7E) transfected
cells; and (vi) co-immunoprecipitates with PrP
C in the DRM-rich
fractions of OptiPrep
TM gradients (Figure 7F). Altogether, these
results both conﬁrm our ﬁndings and validate the use of GFP–Dpl
as an excellent tool in studying the physiology of Dpl.
DISCUSSION
Dpl and PrP
C, although sharing a similar three-dimensional
structure and amino acid sequence, appear to have antagonistic
functions [8]. In particular it has been shown that Ngsk, ZurichII
and Rcm0 lines of PrP-knockout mice develop late-onset ataxia
[3–5] due to the ectopic overexpression of Dpl in the brains
of these mice [4,5]. Interestingly, the symptoms are rescued by
reintroducing the PrP gene, suggesting a functional interaction
between PrP
C and Dpl [8,13]. Consistent with this hypothesis
an interaction has been suggested to occur in neuronal cells,
but not in testis [19–21]. Furthermore, Dpl seems to affect the
trafﬁcking of PrP
C when co-expressed in polarized epithelial
MDCK cells [29], supporting further the possibility that the two
proteins interact. However, the localization of this interaction and
its physiopathological role are still debated [8,18,20–23].
In order to shed light on these issues, we have studied the
intracellular trafﬁcking of Dpl both in the presence and absence
of PrP
C in transfected polarized FRT cells, which have already
been extensively characterized for the trafﬁcking of PrP
C [30,31].
Speciﬁcally, we asked the question of whether the intracellular
localization of each protein was affected by the presence of the
other,andwhetherandwherethetwoproteinsinteractedindoubly
transfected cells.
Confocal microscopy and biochemical approaches allowed us
to demonstrate that Dpl and PrP
C preferentially distribute in
the Golgi apparatus and on the basolateral cell surface in both
singly and doubly expressing FRT clones, where they partially
co-localize (Figures 1, 2, 7A and 7B).
In contrast with what has been shown in MDCK cells [29],
we found that Dpl and PrP
C do not interfere with each other’s
localization in FRT cells. The discrepancy between the two cell
lines could be explained by the fact that FRT and MDCK cells
differ in the polarized sorting of GPI-anchored proteins [35,36];
Dpl therefore represents another model GPI protein which has an
opposite localization in the two cell lines.
Asglycansareimportantmodiﬁersofthebehaviourofsecretory
proteins, we also analysed the glycoforms of Dpl expressed
alone (results not shown) or together with PrP
C (Figure 3).
Intriguingly, and differently from PrP
C, the unglycosylated band
of Dpl could be detected only upon digestion with PNGase F,
suggesting that the attachment of glycans to this protein occurs
veryefﬁcientlyinFRTcells.Alternativelythedegradationprocess
of unglycosylated Dpl might be very efﬁcient in our model cell
system (Figure 3A). Another distinct feature of Dpl is that it
displayed a partial sensitivity to digestion by endo H (Figures 3A
and 7D). Accordingly, we found that Dpl (most probably its
monoglycosylated form) was partially retained in the cis-t o
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Figure 7 GFP-tagging does not alter the intracellular trafﬁcking of Dpl in FRT cells and its ability to co-immunoprecipitate with PrPC
(A) Doubly transfected FRT cells were grown on coverslips and subjected to immunoﬂuorescence analysis under unpermeabilized conditions. After paraformaldehyde ﬁxation, cells were incubated
with the anti-Dpl polyclonal Q55 antibody (red) and the monoclonal SAF-32 primary antibody (green), and were then incubated with appropriate secondary antibodies. The images were an-
alysed with a confocal microscope; the merge shows the co-localization of Dpl and PrPC on the basolateral cell surface (an optical section, from a Z-stack, near the basolateral surface is shown).
Scale bar, 10μm. (B) Dpl and Dpl and PrPC expressing cells were grown on transwell ﬁlters and selectively biotinylated on the apical (Ap) or basolateral (Bl) surface. Biotinylated Dpl and PrPC
were then isolated from cell lysates by immunoprecipitation with streptavidin beads and detected by immunoblotting with the speciﬁc antibodies (Dpl 151 or SAF-32 respectively). WB, Western
blot. (C) Cells transfected with an untagged Dpl protein were plated on coverslips and ﬁxed with paraformaldehyde. After saponin permeabilization cells were stained with a monoclonal antibody
against Dpl (Dpl 151; green) and a polyclonal antibody against the ER marker calreticulin (CLR; red). Scale bar, 10μm. (D) Sensitivity of Dpl to endo H treatment was analysed after immunoprecipi-
tation (IP) of the protein (with the monoclonal antibody Dpl 151) from the lysates of doubly transfected cells (FRT Dpl+PrPC), after incubation for 16h at 37◦C in the absence (−), or in the
presence (+), of endo H enzyme (see the Experimental section) and immunoblotting with a polyclonal antibody against Dpl (Q55). (*) indicates the band resulting from the enzymatic digestion. L,
lysate. (E) Triton X-100 (1%) lysates from doubly expressing clones grown on 150-mm dishes were run through a two-step (5–30%) OptiPrepTM density gradient, as described in the Experimental
section. Fractions (12 of 1ml each) were collected from the top to the bottom of the tube after centrifugation to equilibrium, and Dpl and PrPC were revealed in each fraction by Western blotting
with the Dpl 151 or the SAF-32 antibodies respectively. (F) The OptiPrepTM density gradient DRM-rich fractions 4 and 5 of doubly transfected FRT cell lysates were ﬁrst immunoprecipitated
(IP)withananti-PrPantibody(SAF-32)andthenrevealedbyWesternblotting(WB)withananti-Dplantibody(Dpl151;toshowco-immunoprecipitation)orananti-PrPantibody(SAF-32;toconﬁrm
immunoprecipitation). The loading control (L, 60μg of cell lysate) and 1/10 of the supernatants (SN) were also analysed.
medial-Golgi complex (Figure 3C). In addition we found Dpl
was also sensitive to endo H digestion in MDCK cells both
when expressed alone (results not shown) or together with PrP
C
(Supplementary Figure S1C) suggesting that differences between
the two cell lines in the polarized sorting of Dpl, and the mis-
sorting of PrP
C, are not regulated by endo H-sensitive glycan
modiﬁcation. Thus, despite the homologous glycosylation sites, a
diversesugarremodellingmightoccurforthetwoproteinsandthis
may be linked to their different function and/or to their different
susceptibilitytoconformationtransition,whichistypicalofPrP
C,
but not of Dpl [9].
As both proteins have been found associated with DRMs in
different cells and tissues [20,24,26], we next analysed their
raft association in singly and doubly transfected FRT clones
(Figures 4 and 7E). Whereas the association of Dpl with DRMs
remained approximately the same in the two clones (65+ −5.3
and 62+ −2.4%), the amount of PrP
C ﬂoating to the DRM-rich
fractions in the doubly transfected cells was lower compared with
thesinglytransfectedones(36+ −1.8and60+ −2.1%respectively)
(Figure 4). Moreover, in cells expressing both PrP
C and Dpl,
cholesterol depletion was not able to induce the dissociation of
the two proteins from DRMs (from 62+ −2.4 to 60+ −1.5% for
GFP–Dpl and from 36+ −1.8 to 33+ −1.5% for PrP
C), which was
observedinsinglyexpressingclones(from65+ −5.3to35+ −2.4%
of GFP–Dpl and from 60+ −2 . 1t o3 0+ −1.3% of PrP
C; Figure 4).
We speculate that the expression of Dpl could modulate the
capacity of PrP
C to associate with lipid rafts inducing it to
move to a less-ordered lipid microenvironment. Nevertheless,
we show that the two proteins co-immunoprecipitate exclusively
from DRMs (Figure 5). Importantly, the integrity of these
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domains appeared to be essential for the interaction of the
two proteins, as demonstrated by the reduction in the co-
immunoprecipitated protein levels after cholesterol depletion
(Figures 5A and B). Although the interaction between PrP
C and
Dpl has been suggested previously [18,19,21], our results provide
the ﬁrst clear evidence that this interaction occurs in speciﬁc
membrane microdomains (rafts) and is dependent on cholesterol.
Our results are consistent with the ﬁnding that in neuronal cells
the two proteins were found to reside in the same membrane
microdomains [24] and with the fact that in testis, where the two
proteins do not co-immunoprecipitate, they reside in different
membrane environments [20].
The demonstration that PrP
C and Dpl interact in rafts could
be of importance, considering the relevance of membrane micro-
domainsinthepathogenesisofprionandotherneurodegenerative
diseases [26,27,45,46]. The association of these proteins to
differentorthesameraftscouldaccountfortheirdifferentfunction
in different tissues, supporting the hypothesis that PrP
C,w h e n
interactingwithDplinraftsofneurons,isabletoblockitstoxicity.
Finally, on the basis of co-immunoprecipitation experiments, we
show in the present study that PrP
C and Dpl form a complex with
ﬂotillin-2 in singly and doubly transfected clones (Figure 6). This
ﬁnding is quite interesting considering that interaction with ﬂo-
tillins has been suggested to have a role in the physiological func-
tionofPrP
C;itcanleadtoactivationofERK(extracellular-signal-
regulated kinase) 1/2 upon PrP
C capping in T-cells [43], and can
trigger the formation of Ca
2+-independent PrP
C-mediated cell ad-
hesions in S2 cells [44]. Moreover, on one hand ﬂotillin-1, which
forms a heterocomplex with ﬂotillin-2 in N2a cells, has been
reported to interact with neuroglobin, a protein involved in neuro-
protective pathways [47], and on the other hand ﬂotillin levels
are increased in Alzheimers-disease-affected brains [48]. Inter-
estinglyPrP
Sc wasshowntoaccumulateinﬂotillin-1-positiveves-
icles in infected GT1-7 cells [42], suggesting a possible involve-
mentoftheseraftproteinsinneurotoxicprocesses.Thusconsider-
ingtheantagonisticbehaviourofDplandPrP
C regardingtheonset
of neurodegeneration, it will be interesting to investigate further
whetherandhowthismutualorexclusiveinteractionwithﬂotillin
is involved in the signalling function of both proteins and/or in
the pathways leading to neurodegeneration. Indeed it is tempting
to speculate that during embryogenesis, when both proteins are
present, PrP
C and Dpl together transduce a beneﬁcial signal
through a complex containing ﬂotillin-2. Accordingly, one could
hypothesizethatthecomplexgetsdisrupted,and/ormalfunctions,
ifDpldoesnotinteractwithPrP
C (i.e.intheabsenceofPrP
C)thus
reversing the beneﬁcial effect of a neuroprotective signal.
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Doppel and PrPC co-immunoprecipitate in detergent-resistant membrane
domains of epithelial FRT cells
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Figure S1 Co-expression of Dpl directs PrPC to the apical cell surface of polarized MDCK cells
(A) MDCK cells expressing Dpl and PrPC (MDCK Dpl+PrPC) cells were ﬁxed with 2% (w/v) paraformaldehyde and incubated for 20 min with the monoclonal antibody SAF-32, against PrP, and
the polyclonal antibody Q55, against Dpl, and secondary FITC- and TRITC-conjugated antibodies were used to reveal PrPC and Dpl respectively. Images were acquired with a Zeiss laser confocal
microscope(LSCM510).Scalebar,10μm.(B)Aftergrowthontranswellﬁltersfor4days,singly(MDCKPrPC),ordoubly(MDCKDpl+PrPC),transfectedMDCKcellswereselectivelybiotinylated
fromtheapical(Ap)orbasolateral(Bl) surfaceoftheplasmamembrane.Biotinylated DplandPrPC werethenrecoveredfromcelllysatesbyimmunoprecipitationwith streptavidinbeadsanddetected
by immunoblotting with speciﬁc antibodies (Dpl 151 and SAF-32 antibodies respectively). Note that when PrPC is co-transfected with Dpl its polarity is reversed (from basolateral to apical) and it is
found localized on the apical surface like Dpl. (C) Native Dpl immunoprecipitated (IP) from MDCK Dpl+PrPC cell lysates was digested with (+) and without (−) endo H (Endo-H) at 37◦C for 16 h
and subjected to SDS/PAGE followed by Western blot analysis with the anti-Dpl Q55 antibody. (*) indicates the band resulting from the enzymatic digestion, indicating a partial sensitivity of Dpl to
endo H. L, lysate.
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Figure S2 Co-immunoprecipitation between GFP–Dpl and PrPC using an
anti-PrP antibody in the precipitation step
TheOptiPrepTM densitygradientDRMfractions(4–5)ofFRTGFP–Dpl+PrPC clonelysatewere
ﬁrst immunoprecipitated (IP) with the anti-PrP antibody and then revealed by Western blotting
(Wb) with anti-GFP antibody (to reveal the co-immunoprecipitation) or anti-PrP antibody (to
revealtheimmmunoprecipitation).Theloadingcontrol(L,60μgofcelllysate),thepre-clearing
(PC) and 1/10 of the supernatants (SN) were also analysed.
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